Antidepressant-linked overdose deaths in US have climbed for two decades
Overdoses involving antidepressants have consistently risen in the US, with significant implications for public health, particularly amid the opioid epidemic. [ more ]
Opioid overdose deaths in the U.S. have slightly declined but remain high, primarily attributed to fentanyl. The trend may not signify a permanent turn, but there are hopeful signs. [ more ]
Antidepressant-linked overdose deaths in US have climbed for two decades
Overdoses involving antidepressants have consistently risen in the US, with significant implications for public health, particularly amid the opioid epidemic. [ more ]
Opioid overdose deaths in the U.S. have slightly declined but remain high, primarily attributed to fentanyl. The trend may not signify a permanent turn, but there are hopeful signs. [ more ]
What to Know About the Purdue Pharma Case Before the Supreme Court
The Supreme Court heard arguments over a bankruptcy deal for Purdue Pharma that would shield the Sackler family from additional opioid-related lawsuits.
The court's decision could have significant consequences for other cases that use the bankruptcy system to settle mass injury claims. [ more ]
Supreme Court Appears Split Over Opioid Settlement for Purdue Pharma
The Supreme Court justices are divided on the bankruptcy settlement for Purdue Pharma that would shield the Sackler family from civil lawsuits related to the opioid epidemic.
The case raises questions about the practical effect of unraveling the agreement and the broader concerns over the Sacklers' liability in the opioid crisis. [ more ]
It's money v. principle in Supreme Court opioid case
The Supreme Court is considering a challenge to a deal that would compensate victims of the opioid epidemic while protecting the Sackler family from lawsuits.
The justices are grappling with the dilemma of prioritizing money or principle in deciding the fate of the multi-billion dollar Purdue Pharma bankruptcy deal. [ more ]
What to Know About the Purdue Pharma Case Before the Supreme Court
The Supreme Court heard arguments over a bankruptcy deal for Purdue Pharma that would shield the Sackler family from additional opioid-related lawsuits.
The court's decision could have significant consequences for other cases that use the bankruptcy system to settle mass injury claims. [ more ]
Supreme Court Appears Split Over Opioid Settlement for Purdue Pharma
The Supreme Court justices are divided on the bankruptcy settlement for Purdue Pharma that would shield the Sackler family from civil lawsuits related to the opioid epidemic.
The case raises questions about the practical effect of unraveling the agreement and the broader concerns over the Sacklers' liability in the opioid crisis. [ more ]
It's money v. principle in Supreme Court opioid case
The Supreme Court is considering a challenge to a deal that would compensate victims of the opioid epidemic while protecting the Sackler family from lawsuits.
The justices are grappling with the dilemma of prioritizing money or principle in deciding the fate of the multi-billion dollar Purdue Pharma bankruptcy deal. [ more ]